Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
暂无分享,去创建一个
I. Seong | Seung‐Jung Park | S. Yun | Young-Hak Kim | J. Ko | M. Hong | Duk‐Woo Park | Cheol-Whan Lee | Seung‐Whan Lee | Seong-Wook Park | Jae‐Hwan Lee | Jae‐Hyeong Park | N. Lee | Y. Cho | J. Kim | K. Chun | Si-Wan Choi | Hyun-Sook Kim
[1] P. Chan,et al. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus. , 2007, The American journal of cardiology.
[2] T. Ahn,et al. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes , 2006, Heart.
[3] R. Morishita. A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosis. , 2005, Atherosclerosis. Supplements.
[4] Seung‐Jung Park,et al. Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era. , 2005, The American journal of cardiology.
[5] E. Orav,et al. Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials , 2005, Circulation.
[6] C. Grines,et al. Coronary Stent Restenosis in Patients Treated With Cilostazol , 2005, Circulation.
[7] E. Orav,et al. Late Loss in Lumen Diameter and Binary Restenosis for Drug-Eluting Stent Comparison , 2005, Circulation.
[8] G. Stone,et al. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. , 2005, Journal of the American College of Cardiology.
[9] K. Node,et al. Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation. , 2004, Journal of the American College of Cardiology.
[10] Patrick W Serruys,et al. Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: An Evaluation From the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Study , 2004, Circulation.
[11] G. Stone,et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.